Last reviewed · How we verify

NCT06851988

Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients

Recruiting now NA Last updated 28 February 2025
What this trial tests

NA trial testing HIIT & Record of physical activities at home. in Aging in 180 participants. Currently enrolling.

Timeline
3 May 2023
Primary endpoint
30 October 2025
30 October 2027

Quick facts

Lead sponsorChang Gung Memorial Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment180
Start date3 May 2023
Primary completion30 October 2025
Estimated completion30 October 2027
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 20 to 80, any sex, with Aging or High-intensity Interval Training. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of HIIT & Record of physical activities at home.

Trials testing the same drug.

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06851988.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing